AnaptysBio, Inc. Common Stock (NASDAQ: ANAB) last traded at $45.95, down 0.56% on the session. The quote above updates while this page is open; the figures below are drawn from AnaptysBio, Inc. Common Stock’s own filings and are restated only when a new one is published.
AnaptysBio, Inc. Common Stock trades on NASDAQ under the ticker ANAB. Its market capitalisation is $1.37 billion.
Valuation measures for AnaptysBio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.37B |
|---|---|
| Enterprise value | $1.55B |
| Price / sales | 5.91 |
| Price / book | 129.78 |
| Beta | 0.91 |
Trailing-twelve-month figures tagged in AnaptysBio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $232.39M |
|---|---|
| Net income (TTM) | -$26.79M |
| EPS (TTM) | -$1.00 |
| Operating margin | 94.58% |
| Return on equity | -253.07% |
| Cash | $133.83M |
Range and volume for ANAB over the past 52 weeks.
| 52-week high | $72.36 |
|---|---|
| 52-week low | $20.18 |
| Volume | 495.7K |
| Average volume | 564.7K |
| Previous close | $46.21 |
Invest a chosen dollar amount in AnaptysBio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ANAB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.